Legal & General Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109M Sell
498,922
-6,687
-1% -$1.46M 0.03% 497
2025
Q1
$113M Buy
505,609
+18,507
+4% +$4.14M 0.03% 476
2024
Q4
$160M Sell
487,102
-28,686
-6% -$9.4M 0.04% 394
2024
Q3
$155M Buy
515,788
+20,466
+4% +$6.14M 0.04% 409
2024
Q2
$163M Sell
495,322
-12,579
-2% -$4.14M 0.05% 378
2024
Q1
$201M Sell
507,901
-13,368
-3% -$5.29M 0.06% 340
2023
Q4
$184M Sell
521,269
-17,930
-3% -$6.31M 0.06% 334
2023
Q3
$202M Sell
539,199
-5,703
-1% -$2.14M 0.07% 304
2023
Q2
$208M Sell
544,902
-31,558
-5% -$12.1M 0.07% 315
2023
Q1
$200M Sell
576,460
-1,801
-0.3% -$624K 0.07% 310
2022
Q4
$136M Sell
578,261
-43,207
-7% -$10.2M 0.05% 390
2022
Q3
$153M Sell
621,468
-44,749
-7% -$11M 0.06% 353
2022
Q2
$201M Sell
666,217
-53,133
-7% -$16.1M 0.07% 311
2022
Q1
$295M Sell
719,350
-3,771
-0.5% -$1.55M 0.09% 256
2021
Q4
$339M Sell
723,121
-16,135
-2% -$7.57M 0.1% 214
2021
Q3
$314M Buy
739,256
+28,120
+4% +$11.9M 0.1% 213
2021
Q2
$255M Buy
711,136
+70,658
+11% +$25.4M 0.09% 275
2021
Q1
$180M Buy
640,478
+65,449
+11% +$18.4M 0.07% 330
2020
Q4
$163M Buy
575,029
+53,232
+10% +$15.1M 0.06% 339
2020
Q3
$143M Buy
521,797
+158,555
+44% +$43.6M 0.06% 323
2020
Q2
$82.5M Buy
363,242
+18,256
+5% +$4.14M 0.04% 447
2020
Q1
$52.5M Buy
344,986
+27,423
+9% +$4.18M 0.03% 506
2019
Q4
$47.7M Buy
317,563
+189,850
+149% +$28.5M 0.02% 612
2019
Q3
$18.1M Buy
127,713
+2,844
+2% +$403K 0.01% 807
2019
Q2
$15.6M Buy
124,869
+26,443
+27% +$3.31M 0.01% 850
2019
Q1
$10.8M Buy
98,426
+3,750
+4% +$413K 0.01% 871
2018
Q4
$9.28M Buy
94,676
+6,074
+7% +$595K 0.01% 856
2018
Q3
$10.9M Sell
88,602
-190
-0.2% -$23.5K 0.01% 843
2018
Q2
$8.82M Sell
88,792
-3,534
-4% -$351K 0.01% 886
2018
Q1
$8.15M Buy
92,326
+14,871
+19% +$1.31M 0.01% 884
2017
Q4
$7.64M Buy
77,455
+8,710
+13% +$859K 0.01% 877
2017
Q3
$6.62M Buy
68,745
+7,287
+12% +$702K 0.01% 907
2017
Q2
$5.81M Buy
61,458
+11,970
+24% +$1.13M ﹤0.01% 911
2017
Q1
$4.04M Buy
49,488
+25,377
+105% +$2.07M ﹤0.01% 1049
2016
Q4
$2.05M Buy
24,111
+11,557
+92% +$981K ﹤0.01% 1371
2016
Q3
$935K Buy
12,554
+2,611
+26% +$194K ﹤0.01% 1426
2016
Q2
$755K Sell
9,943
-8,434
-46% -$640K ﹤0.01% 1234
2016
Q1
$1.27M Buy
18,377
+1,669
+10% +$115K ﹤0.01% 1060
2015
Q4
$1.02M Buy
16,708
+608
+4% +$37.1K ﹤0.01% 1152
2015
Q3
$878K Buy
16,100
+2,934
+22% +$160K ﹤0.01% 1146
2015
Q2
$764K Buy
13,166
+671
+5% +$38.9K ﹤0.01% 1207
2015
Q1
$744K Buy
12,495
+2,288
+22% +$136K ﹤0.01% 1192
2014
Q4
$551K Sell
10,207
-308
-3% -$16.6K ﹤0.01% 1227
2014
Q3
$469K Buy
+10,515
New +$469K ﹤0.01% 1212